# Medicover increases ownership in NIPD Genetics to 87.2%

Medicover AB committed to acquire shares from existing shareholders to increase its ownership in NIPD Genetics from 18.9% to 87.2%. The purchase price for the 68.3% stake is EUR 44.4 million, implying an enterprise value of EUR 65.0 million.

- Type: Acquisition
- Announced: 2021-12-09
- Where: Cyprus
- Value: $50.0M (44.4M EUR)
- Status: announced
- Products: in vitro genetic testing solutions
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Medicover AB](https://endata.com/companies/67176.md) (acquirer)
- [NIPD Genetics](https://endata.com/companies/67177.md) (target)

## Sources

- [inderes.dk](https://www.inderes.dk/en/releases/medicover-increased-ownership-in-nipd-genetics), 2022-12-08: "NIPD's proprietary technology platform together with their experienced expert team and Medicover Genetics state-of-the art diagnostics will take us one step closer to become an international market leader in genetic diagnostics"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.